Consulta con un profesional de salud antes de usarlo si ests bajo tratamiento o padeces enfermedades crnicas
GLP-1 receptor agonists mimic or enhance the action of glucagon-like peptide-1, an incretin hormone involved in post-meal glucose control, insulin secretion, glucagon suppression, gastric emptying, appetite, and satiety
Reversal of chemically induced deficits: Rodents given Dihexa reversed scopolamine-induced water-maze impairment in the 2013 characterization work a paper now under a Notice of Concern [1] [2]
Some studies reported reduced microbial diversity, suggesting that its effects may vary depending on host metabolic status, dietary patterns, and comorbidities [84]
Tara *Based on internal survey 416 GLP-1 users in 2025 **Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss within the WW Clinic Program and participating in the GLP-1 companion nutrition program